Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome

Metabolic programs are crucial for regulatory T (T reg) cell stability and function, but the underlying mechanisms that regulate T reg cell metabolism are elusive. Here, we report that lysosomal TRAF3IP3 acts as a pivotal regulator in the maintenance of T reg cell metabolic fitness. T reg–specific deletion of Traf3ip3 impairs T reg cell function, causing the development of inflammatory disorders and stronger antitumor T cell responses in mice. Excessive mechanistic target of rapamycin complex 1 (mTORC1)–mediated hyper-glycolytic metabolism is responsible for the instability of TRAF3IP3-deficient T reg cells. Mechanistically, TRAF3IP3 restricts mTORC1 signaling by recruiting the serine-threonine phosphatase catalytic subunit (PP2Ac) to the lysosome, thereby facilitating the interaction of PP2Ac with the mTORC1 component Raptor. Our results define TRAF3IP3 as a metabolic regulator in T reg cell stability and function and suggest a lysosome-specific mTORC1 signaling mechanism that regulates T reg cell metabolism.

[1]  T. P. Neufeld,et al.  Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.

[2]  A. Rudensky,et al.  Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus , 2014, Cell.

[3]  J. Locasale,et al.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. , 2015, The Journal of clinical investigation.

[4]  Devin K. Schweppe,et al.  Architecture of the human interactome defines protein communities and disease networks , 2017, Nature.

[5]  H. Chi,et al.  mTOR signaling in the differentiation and function of regulatory and effector T cells. , 2017, Current opinion in immunology.

[6]  K. Guan,et al.  Amino acid signalling upstream of mTOR , 2013, Nature Reviews Molecular Cell Biology.

[7]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[8]  W. Linehan,et al.  Ionic immune suppression within the tumour microenvironment limits T cell effector function , 2016, Nature.

[9]  G. Tsokos,et al.  Protein phosphatase 2A is requisite for the function of regulatory T cells , 2015, Nature Immunology.

[10]  Nicolai J. Birkbak,et al.  Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors , 2017, Immunity.

[11]  D. Sabatini,et al.  Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.

[12]  D. M. Smith,et al.  Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis , 2017, Immunity.

[13]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[14]  Hongbo Hu,et al.  T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi , 2015, The Journal of experimental medicine.

[15]  F. Marelli-Berg,et al.  Metabolic Regulation of Regulatory T Cell Development and Function , 2014, Front. Immunol..

[16]  Peter Vogel,et al.  mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.

[17]  J. Bluestone,et al.  The phosphatase PTEN-mediated control of PI-3 kinase in T regs cells maintains homeostasis and lineage stability , 2015 .

[18]  S. Akira,et al.  Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells , 2012, Nature Immunology.

[19]  D. Green,et al.  Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis , 2015, Nature Immunology.

[20]  Joao C. Guimaraes,et al.  Roquin Suppresses the PI3K‐mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells , 2017, Immunity.

[21]  Xia Yang,et al.  The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells. , 2017, Immunity.

[22]  L. Turka,et al.  Immunometabolism of regulatory T cells , 2016, Nature Immunology.

[23]  R. Dobrowsky,et al.  Ceramide activates heterotrimeric protein phosphatase 2A. , 1993, The Journal of biological chemistry.

[24]  H. Chi,et al.  Regulatory T cells require the phosphatase PTEN to restrain type 1 and follicular helper T-cell responses , 2015, Nature Immunology.

[25]  Greg M. Delgoffe,et al.  Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8 T cell differentiation , 2016, Nature Immunology.

[26]  S. Schweiger,et al.  Control of mTORC1 signaling by the Opitz syndrome protein MID1 , 2011, Proceedings of the National Academy of Sciences.

[27]  J. Jaworski,et al.  Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR). , 2013, Biochimica et biophysica acta.

[28]  D. M. Smith,et al.  Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis , 2018, Immunity.

[29]  Peirong Yang,et al.  USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses , 2014, Nature Immunology.

[30]  M. Warmoes,et al.  Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression , 2016, Nature Immunology.

[31]  S. Miyamoto,et al.  Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II , 2008, Cell Death and Differentiation.

[32]  C. Benner,et al.  Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity , 2014, Cell.

[33]  P. Pandolfi,et al.  PML Regulates Apoptosis at Endoplasmic Reticulum by Modulating Calcium Release , 2010, Science.

[34]  R. Alon.  A Sweet Solution: Glycolysis-Dependent Treg Cell Migration. , 2017, Immunity.

[35]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[36]  C. Betz,et al.  Where is mTOR and what is it doing there? , 2013, The Journal of cell biology.

[37]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[38]  Hongbo Chi,et al.  Regulation and function of mTOR signalling in T cell fate decisions , 2012, Nature Reviews Immunology.

[39]  Jason A. Koutcher,et al.  Identification of a tumour suppressor network opposing nuclear Akt function , 2006, Nature.

[40]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[41]  Brian Raught,et al.  A PP2A Phosphatase High Density Interaction Network Identifies a Novel Striatin-interacting Phosphatase and Kinase Complex Linked to the Cerebral Cavernous Malformation 3 (CCM3) Protein*S , 2009, Molecular & Cellular Proteomics.

[42]  Edward Y Kim,et al.  Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction. , 2014, The Journal of clinical investigation.